Raungrut, P.; Jirapongsak, J.; Tanyapattrapong, S.; Bunsong, T.; Ruklert, T.; Kueakool, K.; Thongsuksai, P.; Nakwan, N.
Fibrinogen Alpha Chain as a Potential Serum Biomarker for Predicting Response to Cisplatin and Gemcitabine Doublet Chemotherapy in Lung Adenocarcinoma: Integrative Transcriptome and Proteome Analyses. Int. J. Mol. Sci. 2025, 26, 1010.
https://doi.org/10.3390/ijms26031010
AMA Style
Raungrut P, Jirapongsak J, Tanyapattrapong S, Bunsong T, Ruklert T, Kueakool K, Thongsuksai P, Nakwan N.
Fibrinogen Alpha Chain as a Potential Serum Biomarker for Predicting Response to Cisplatin and Gemcitabine Doublet Chemotherapy in Lung Adenocarcinoma: Integrative Transcriptome and Proteome Analyses. International Journal of Molecular Sciences. 2025; 26(3):1010.
https://doi.org/10.3390/ijms26031010
Chicago/Turabian Style
Raungrut, Pritsana, Jirapon Jirapongsak, Suchanan Tanyapattrapong, Thitaya Bunsong, Thidarat Ruklert, Kannika Kueakool, Paramee Thongsuksai, and Narongwit Nakwan.
2025. "Fibrinogen Alpha Chain as a Potential Serum Biomarker for Predicting Response to Cisplatin and Gemcitabine Doublet Chemotherapy in Lung Adenocarcinoma: Integrative Transcriptome and Proteome Analyses" International Journal of Molecular Sciences 26, no. 3: 1010.
https://doi.org/10.3390/ijms26031010
APA Style
Raungrut, P., Jirapongsak, J., Tanyapattrapong, S., Bunsong, T., Ruklert, T., Kueakool, K., Thongsuksai, P., & Nakwan, N.
(2025). Fibrinogen Alpha Chain as a Potential Serum Biomarker for Predicting Response to Cisplatin and Gemcitabine Doublet Chemotherapy in Lung Adenocarcinoma: Integrative Transcriptome and Proteome Analyses. International Journal of Molecular Sciences, 26(3), 1010.
https://doi.org/10.3390/ijms26031010
